Agios Pharmaceuticals Q4 EPS $(1.86) Beats $(1.94) Estimate, Sales $19.967M Beat $12.014M Estimate

Agios Pharmaceuticals (NASDAQ:AGIO) reported quarterly losses of $(1.86) per share which beat the analyst consensus estimate of $(1.94) by 3.93 percent. This is a 4.12 percent increase over losses of $(1.94) per share from the same period last year. The company reported quarterly sales of $19.967 million which beat the analyst consensus estimate of $12.014 million by 66.20 percent. This is a 86.61 percent increase over sales of $10.700 million the same period last year.